Skip to main content
Log in

Suicide in Stroke Survivors: Epidemiology and Prevention

  • Review Article
  • Published:
Drugs & Aging Aims and scope Submit manuscript

Abstract

Stroke is a dramatic event and is associated with potentially severe consequences, including disability, mortality, and social costs. Stroke may occur at any age; however, most strokes occur in individuals aged 65 years and older. Previous research has found that stroke increases suicide risk, especially among women and younger patients. The aim of the current review is to investigate the relationship between suicide and stroke in order to determine which stroke patients are at elevated risk for suicide. Moreover, we review the literature in order to provide pharmacological treatment strategies for stroke patients at high risk of suicide. We performed a careful search to identify articles and book chapters focused on this issue, selecting only English-language articles published from 1990 to 2014 that addressed the issue of suicide after stroke and its pharmacological management. We found 12 clinical trials that explored the relationship between stroke and suicidal ideation and/or suicidal plans and 11 investigating suicide as the cause of death after stroke. We identified stroke as a significant risk factor for both suicide and suicidal ideation, especially among younger adult depressed patients in all articles, providing further support for the association between post-stroke and suicidality. Suicide risk is particularly high in the first 5 years following stroke. Depression, previous mood disorder, prior history of stroke, and cognitive impairment were found to be the most important risk factors for suicide. Selective serotonin reuptake inhibitors (SSRIs) represent the treatment of choice for stroke survivors with suicide risk, and studies in rats have suggested that carbolithium is a promising treatment in these patients. Early identification and treatment of post-stroke depression may significantly reduce suicide risk in stroke patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Tran J, Mirzaei M, Anderson L, Leeder SR. The epidemiology of stroke in the Middle East and North Africa. J Neurol Sci. 2010 15;295(1–2):38–40.

  2. Mackay J, Mensah G. The Globan burden of stroke. In: The atlas of heart disease and stroke. Geneva: World Health Organization. 2004. http://www.who.int/cardiovascular_diseases/en/cvd_atlas_15_burden_stroke.pdf. Accessed 26 Nov 2014.

  3. Lloyd-Jones D, Adams RJ, Brown TM, et al. AHA heart disease and stroke statistics—2010 update: a report from the American Heart Association. Circulation. 2010;121:46–215.

    Article  Google Scholar 

  4. Gustavsson A, Svensson M, Jacobi F, et al. Cost of disorders of the brain in Europe 2010. Eur Neuropsychopharmacol. 2011;21:718–79.

    Article  CAS  PubMed  Google Scholar 

  5. Mukherjee D, Patil CG. Epidemiology and the global burden of stroke. World Neurosurg. 2011;76(6):85–90.

    Article  Google Scholar 

  6. Centers for Disease Control and Prevention. In: CDC Vitalsigns Preventable Deaths from Heart Disease and Stroke. 2013. http://www.cdc.gov/vitalsigns/pdf/2013-09-vitalsigns.pdf. Accessed 26 Nov 2014.

  7. Di Carlo A. Human and economic burden of stroke. Age Ageing. 2009;38:4–5.

    Article  PubMed  Google Scholar 

  8. Brønnum-Hansen H, Davidsen M, Thorvaldsen P, Danish MONICA Study Group. Long-term survival and causes of death after stroke. Stroke. 2001;32(9):2131–6.

    Article  PubMed  Google Scholar 

  9. Pompili M, Innamorati M, Venturini P, Serafini G, Lester D, Girardi R. Child abuse as a risk factor for suicide in life: a selective overview. Minerva Psichiatr. 2011;52(1):61–9.

    Google Scholar 

  10. Harris EC, Barraclough B. Suicide as an outcome for mental disorders. A meta-analysis. Br J Psychiatry. 1997;170:205–28.

    Article  CAS  PubMed  Google Scholar 

  11. Juurlink DN, Herrmann N, Szalai JP, et al. Medical illness and the risk of suicide in the elderly. Arch Intern Med. 2004;164(11):1179–84.

    Article  PubMed  Google Scholar 

  12. Quan H, Arboleda-Florez J, Fick GH, et al. Association between physical illness and suicide among the elderly. Soc Psychiatry Psychiatr Epidemiol. 2002;37(4):190–7.

    Article  PubMed  Google Scholar 

  13. Mackenzie TB, Popkin MK. Suicide in medical patient. Int J Psichiatr Med. 1987;17(1):3–22.

    Article  CAS  Google Scholar 

  14. Arciniegas DB, Anderson CA. Suicide in neurologic illness. Curr Treat Options Neurol. 2002;4(6):457–68.

    Article  PubMed  Google Scholar 

  15. Hadidi N, Treat-Jacoboson DJ, Lindquist R. Poststroke depression and functional outcome: a critical review of literature. Heart Lung. 2009;38(2):151–62.

    Article  PubMed  Google Scholar 

  16. Beekman AT, Penninx BW, Deeg DJ, Ormel J, Smit JH, Braam AW, Van Tilburg W. Depression in survivor of stroke: a community-based study of prevalence, risk factors and consequences. Soc Psychiatry Psychiatr Epidemiol. 1998;33(10):463–70.

    Article  CAS  PubMed  Google Scholar 

  17. Pompili M, Venturini P, Campi S, Seretti ME, Montebovi F, Lamis DA, Serafini G, Amore M, Girardi P. Do stroke patients have an increased risk of developing suicidal ideation or dying by suicide? An overview of the current literature. CNS Neurosci Ther. 2012;18(9):711–21.

    Article  PubMed  Google Scholar 

  18. Park SM. Health status and suicidal ideation in Korean elderly: the role of living arrangement. J Ment Health. 2014;23(2):94–8.

    Article  PubMed  Google Scholar 

  19. Shin KM, Cho SM, Hong CH, Park KS, Shin YM, Lim KY, Koh SH. Suicide among the elderly and associated factors in South Korea. Aging Ment Health. 2013;17(1):109–14.

    Article  PubMed  Google Scholar 

  20. Kishi Y, Kosier JT, Robinson RG. Suicidal plans in patients with acute stroke. J Nerv Ment Dis. 1996;184:274–80.

    Article  CAS  PubMed  Google Scholar 

  21. Kishi Y, Robinson RG, Kosier JT. Suicidal plans in patients with stroke: comparison between acute-onset and delayed-onset suicidal plans. Int Psychogeriatr. 1996;8:623–34.

    Article  CAS  PubMed  Google Scholar 

  22. Pohjasvaara T, Vataja R, Leppävuori A, Kaste M, Erkinjuntti T. Suicidal ideas in stroke patients 3 and 15 months after stroke. Cerebrovasc Dis. 2001;12:21–6.

    Article  CAS  PubMed  Google Scholar 

  23. Rao R, Jackson S, Howard R. Neuropsychological impairment in stroke, carotid stenosis, and peripheral vascular disease, a comparison with healthy community residents. Stroke. 1999;30:2167–73.

    Article  CAS  PubMed  Google Scholar 

  24. Santos CO, Caeiro L, Ferro JM, Figueira ML. A study of suicidal thoughts in acute stroke patients. J Stroke Cerebrovasc Dis. 2012;21(8):749–54.

    Article  PubMed  Google Scholar 

  25. Fuller-Thomson E, Tulipano MJ, Song M. The association between depression, suicidal ideation, and stroke in a population-based sample. Int J Stroke. 2012;7(3):188–94.

    PubMed  Google Scholar 

  26. Tang WK, Lu JY, Mok V, Ungvari GS, Wong KS. Is fatigue associated with suicidality in stroke? Arch Phys Med Rehabil. 2011;92:1336–1338.

  27. Tang WK, Liang H, Mok V, Ungvari GS, Wong KS. Is pain associated with suicidality in stroke? Arch Phys Med Rehabil. 2013;94(5):863–6.

    Article  PubMed  Google Scholar 

  28. Tang WK, Lu JY, Liang H, Chan TT, Mok V, Ungvari GS, Wong KS. Is insomnia associated with suicidality in stroke? Arch Phys Med Rehabil. 2011;92(12):2025–7.

    Article  PubMed  Google Scholar 

  29. Chan SS, Lyness JM, Conwell Y. Do cerebrovascular factors confer risk for suicide in later life? A case-control study. Am J Geriatr Psychiatry. 2007; 15:541–544.

  30. Yamauchi T, Inagaki M, Yonemoto N, Iwasaki M, Inoue M, Akechi T, Iso H, Tsugane S. Death by Suicide and other externally caused injuries after stroke in Japan (1990–2010): The Japan Public Health Center-Based Prospective Study. Psychosom Med. 2014;76(6):452–9.

    Article  PubMed  Google Scholar 

  31. Stenager EN, Madsen C, Stenager E, Boldsen J. Suicide in patients with stroke: epidemiological study. BMJ. 1998;316:1206.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  32. Teasdale TW, Engberg AW. Suicide after a stroke: a population study. J Epidemiol Community Health. 2001;55(12):863–6.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  33. Forsström E, Hakko H, Nordström T, Räsänen P, Mainio A. Suicide in patients with stroke: a population-based study of suicide victims during the years 1988–2007 in northern Finland. J Neuropsychiatry Clin Neurosci. 2010;22:182–7.

    Article  PubMed  Google Scholar 

  34. Katayama M, Naritomi H, Oomura M, et al. Case reports of unexpected suicides in patients within 6 months after stroke. Kobe J Med Sci. 2010;56:184–94.

    Google Scholar 

  35. Garden FH, Garrison SJ, Jain A. Assessing suicide risk in stroke patients: review of two cases. Arch Phys Med Rehabil. 1990;71:1003–1005.

  36. Scott KM, Hwang I, Chiu WT, et al. Chronic physical conditions and their association with first onset of suicidal behavior in the world mental health surveys. Psychosom Med. 2010;72:712–9.

    Article  PubMed  Google Scholar 

  37. Voaklander DC, Rowe BH, Dryden DM, Pahal J, Saar P, Kelly KD. Medical illness, medication use and suicide in seniors: a population-based case-control study. J Epidemiol Community Health. 2008;62:138–46.

    Article  CAS  PubMed  Google Scholar 

  38. Placido A, Sposito AC. Association between suicide and cardiovascular disease: time series of 27 years. Int J Cardiol. 2009;135:261–2.

    Article  PubMed  Google Scholar 

  39. Webb RT, Kontopantelis E, Doran T, Qin P, Creed F, Kapur N. Suicide risk in primary care patients with major physical diseases: a case-control study. Arch Gen Psychiatry. 2012;69(7):671.

    Article  Google Scholar 

  40. Crump C, Sundquist K, Sundquist J, Winkleby MA. Sociodemographic, psychiatric and somatic risk factors for suicide: a Swedish national cohort study. Psychol Med. 2014;44(2):279–89.

    Article  CAS  PubMed  Google Scholar 

  41. Flaster M, Sharma A, Rao M. Poststroke depression: a review emphasizing the role of prophylactic treatment and synergy with treatment for motor recovery. Top Stroke Rehabil. 2013;20(2):139–50.

    Article  PubMed  Google Scholar 

  42. Williams LS, Ghose SS, Swindle RW. Depression and other mental health diagnoses increase mortality risk after ischemic stroke. Am J Psychiatry. 2004;161(6):1090–5.

    Article  PubMed  Google Scholar 

  43. Yuan H, Zhang N, Wang C, Luo BY, Shi Y, Li J, Zhou Y, Wang Y, Zhang T, Zhou J, Zhao X, Wang Y. Factors of Hamilton depression rating scale (17 items) at 2 weeks correlated with poor outcome at 1 year in patients with ischemic stroke. Neurol Sci. 2014;35(2):171–7.

    Article  PubMed  Google Scholar 

  44. Raskind MA. Diagnosis and treatment of depression comorbid with neurologic disorders. Am J Med. 2008;121(11 Suppl 2):28–37.

    Article  Google Scholar 

  45. Hackett ML, Carter G, Crimmins D, Clarke T, Maddock K, Sturm JW. Improving outcomes after stroke clinical pilot trial protocol. Int J Stroke. 2010;5(1):52–6.

  46. Baldwin RC. Preventing late-life depression: a clinical update. Int Psychogeriatr. 2010;22(8):1216–24.

    Article  PubMed  Google Scholar 

  47. Mikami K, Jorge RE, Adams HP Jr, Davis PH, Leira EC, Jang M, Robinson RG. Effect of antidepressants on the course of disability following stroke. Am J Geriatr Psychiatry. 2011;19(12):1007–15.

    Article  PubMed Central  PubMed  Google Scholar 

  48. Bilge C, Koçer E, Koçer A, Türk Börü U. Depression and functional outcome after stroke: the effect of antidepressant therapy on functional recovery. Eur J Phys Rehabil Med. 2008;44(1):13–8.

    CAS  PubMed  Google Scholar 

  49. Gottfries CG. Late life depression. Eur Arch Psychiatry Clin Neurosci. 2001;251(2):57–61.

    Article  Google Scholar 

  50. Carota A, Bogousslavsky J. Poststroke depression. Adv Neurol. 2003;92:435–45.

    PubMed  Google Scholar 

  51. Capaldi VF 2nd, Wynn GH. Emerging strategies in the treatment of poststroke depression and psychiatric distress in patients. Psychol Res Behav Manag. 2010;3:109–18.

    Article  PubMed Central  PubMed  Google Scholar 

  52. Narushima K, Robinson RG. The effect of early versus late antidepressant treatment on physical impairment associated with poststroke depression: is there a time-related therapeutic window? J Nerv Ment Dis. 2003;191(10):645–52.

    Article  PubMed  Google Scholar 

  53. Chan KL, Campayo A, Moser DJ, Arndt S, Robinson RG. Aggressive behavior in patients with stroke: association with psychopathology and results of antidepressant treatment on aggression. Arch Phys Med Rehabil. 2006;87(6):793–8.

    Article  PubMed  Google Scholar 

  54. Cravello L, Caltagirone C, Spalletta G. The SNRI venlafaxine improbe emotional unawareness in patients with post-stroke depression. Hum Psychopharmacol. 2009;24(4):331–6.

    Article  CAS  PubMed  Google Scholar 

  55. Conn DK, Steingart AB. Diagnosis and management of late life depression: a guide for the primary care physician. Int J Psychiatry Med. 1997;27(3):269–81.

    Article  CAS  PubMed  Google Scholar 

  56. Shima S. The efficacy of antidepressants in post-stroke depression. Keio J Med. 1997;46(1):25–6.

    Article  CAS  PubMed  Google Scholar 

  57. Pompili M, Rihmer Z, Innamorati M, Lester D, Girardi P, Tatarelli R. Assessment and treatment of suicide risk in bipolar disorders. Expert Rev Neurother. 2009;9(1):109–36.

    Article  PubMed  Google Scholar 

  58. Hackett ML, Anderson CS, House A, Halteh C. Interventions for preventing depression after stroke. Cochrane Database Syst Rev. 2008;16(3):CD003689

  59. Lincoln NB, Flannaghan T, Sutcliffe L, Rother L. Evaluation of cognitive behavioural treatment for depression after stroke: a pilot study. Clin Rehabil. 1997;11(2):114–22.

    Article  CAS  PubMed  Google Scholar 

  60. Harmandayan M, Romanowicz M, Sola C. Successful use of ECT in post-stroke depression. Gen Hosp Psychiatry. 2012;34(1):102.e5–6.

  61. Riva-Posse P, Hermida AP, McDonald WM. The role of electroconvulsive and neuromodulation therapies in the treatment of geriatric depression. Psychiatr Clin North Am. 2013;36(4):607–30.

    Article  PubMed  Google Scholar 

  62. Huang H, Chen K, Guo T, Zhang Y, Qu W, Zhou Z, Liu G, Chen L. Treatment with carotid angioplasty stent placement for post-stroke depression compared to antidepressants. Neurosciences (Riyadh). 2012;17(1):53–6.

    Google Scholar 

  63. Joubert J, Joubert L, Reid C, Barton D, Cumming T, Mitchell P, House M, Heng R, Meadows G, Walterfang M, Pantelis C, Ames D, Davis S. The positive effect of integrated care on depressive symptoms in stroke survivors. Cerebrovasc Dis. 2008;26(2):199–205.

    Article  PubMed  Google Scholar 

  64. Graven C, Brock K, Hill K, Ames D, Cotton S, Joubert L. From rehabilitation to recovery: protocol for a randomised controlled trial evaluating a goal-based intervention to reduce depression and facilitate participation post-stroke. BMC Neurol. 2011;18(11):73.

    Article  Google Scholar 

  65. Hawton K, van Heeringen K. Suicide. Lancet. 2009;373:1372–81.

    Article  PubMed  Google Scholar 

  66. Ellis C, Zhao Y, Egede L. Depression and increased risk of death in adults with stroke. J Psychosom Res. 2010;68:545–51.

    Article  PubMed Central  PubMed  Google Scholar 

  67. Staub F, Bogousslavsky J. Post-stroke depression or fatigue. Eur Neurol. 2001;45:3–5.

    Article  CAS  PubMed  Google Scholar 

  68. Saravane D, Feve B, Frances Y, et al. Drawing up guidelines for the attendance of physical health of patients with severe mental illness. Encephale. 2009;35:330–9.

    Article  CAS  PubMed  Google Scholar 

  69. Williams LS. Depression and stroke: cause or consequence? Semin Neurol. 2005;25:396–409.

    Article  PubMed  Google Scholar 

  70. Cassidy F, Ahearn E, Carroll BJ. Elevated frequency of diabetes mellitus in hospitalized manic-depressive patients. Am J Psychiatry. 1999;156:1417–20.

    CAS  PubMed  Google Scholar 

  71. Kilbourne AM, Cornelius JR, Han X, et al. Burden of general medical conditions among individuals with bipolar disorder. Bipolar Disord. 2004;6:368–73.

    Article  PubMed  Google Scholar 

  72. Golden SH, Lazo M, Carnethon M, et al. Examining a bidirectional association between depressive symptoms and diabetes. JAMA. 2008;299:2751–9.

    Article  PubMed Central  PubMed  Google Scholar 

  73. Eaton WW, Armenian H, Gallo J, Pratt L, Ford DE. Depression and risk for onset of type II diabetes. A prospective population-based study. Diabetes Care. 1996;19:1097–102.

    Article  CAS  PubMed  Google Scholar 

  74. Mezuk B, Eaton WW, Golden SH, Ding Y. The influence of educational attainment on depression and risk of type 2 diabetes. Am J Public Health. 2008;98:1480–5.

    Article  PubMed Central  PubMed  Google Scholar 

  75. McElroy SL, Frye MA, Suppes T. Correlates of overweight and obesity in 644 patients with bipolar disorder. J Clin Psychiatry. 2002;63:207–13.

    Article  PubMed  Google Scholar 

  76. Fagiolini A, Frank E, Scott JA, Turkin S, Kupfer DJ. Metabolic syndrome in bipolar disorder: findings from the Bipolar Disorder Center for Pennsylvanians. Bipolar Disord. 2005;7:424–30.

    Article  PubMed  Google Scholar 

  77. Shah A, Shen N, El-Mallakh RS. Weight gain occurs after onset of bipolar illness in overweight bipolar patients. Ann Clin Psychiatry. 2006;18:239–41.

    Article  PubMed  Google Scholar 

  78. Fiedorowicz JG, Palagummi NM, Forman-Hoffman VL, del Miller D, Haynes WG. Elevated prevalence of obesity, metabolic syndrome, and cardiovascular risk factors in bipolar disorder. Ann Clin Psychiatry. 2008;20:131–7.

    Article  PubMed Central  PubMed  Google Scholar 

  79. Birkenaes AB, Opjordsmoen S, Brunborg C, et al. The level of cardiovascular risk factors in bipolar disorder equals that of schizophrenia: a comparative study. J Clin Psychiatry. 2007;68:917–23.

    Article  PubMed  Google Scholar 

  80. Yates WR, Wallace R. Cardiovascular risk factors in affective disorder. J Affect Disord. 1987;12:129–34.

    Article  CAS  PubMed  Google Scholar 

  81. Johannessen L, Strudsholm U, Foldager L, Munk-Jorgensen P. Increased risk of hypertension in patients with bipolar disorder and patients with anxiety compared to background population and patients with schizophrenia. J Affect Disord. 2006;95:13–7.

    Article  PubMed  Google Scholar 

  82. Patten SB, Williams JV, Lavorato DH, Modgill G, Jette N, Eliasziw M. Major depression as a risk factor for chronic disease incidence: longitudinal analyses in a general population cohort. Gen Hosp Psychiatry. 2008;30:407–13.

    Article  PubMed  Google Scholar 

  83. Davis J, Fujimoto RY, Juarez DT, Hodges KA, Asam JK. Major depression associated with rates of cardiovascular disease state transitions. Am J Manag Care. 2008;14:125–8.

    PubMed  Google Scholar 

  84. Meyer CM, Armenian HK, Eaton WW, Ford DE. Incident hypertension associated with depression in the Baltimore epidemiologic catchment area follow-up study. J Affect Disord. 2004;83:127–33.

    Article  PubMed  Google Scholar 

  85. Kim JM, Kim SW, Kang HJ, Bae KY, Shin IS, Kim JT, Park MS, Park SW, Kim YH, Cho KH, Yoon JS. Serotonergic genes and suicidal ideation 2 weeks and 1 year after stroke in Korea. Am J Geriatr Psychiatry. 2013. doi:S1064-7481(13)00260-1.

  86. Coupland C, Dhiman P, Morriss R, Arthur A, Barton G, Hippisley-Cox J. Antidepressant use and risk of adverse outcomes in older people: population based cohort study. BMJ. 2011;. doi:10.1136/bmj.d4551.

    Google Scholar 

  87. De Coster L, Leentjens AF, Lodder J, Verhey FR. The sensitivity of somatic symptoms in post-stroke depression: a discriminant analytic approach. Int J Geriatr Psychiatry. 2005;20:358–62.

    Article  PubMed  Google Scholar 

  88. Prithard C, Hansen L. Comparison of suicide in people aged 65–74 and 75+ by gender in England and Wales and the major Western countries 1979–1999. Int J Geriatr Psychiatry. 2005;20:17–25.

    Article  Google Scholar 

  89. Van de Port IG, Kwakkel G, Schepers VP, Heinemans CT, Lindeman E. Is fatigue an independent factor associated with activities of daily living, instrumental activities of daily living and health-related quality of life in chronic stroke? Cerebrovasc Dis. 2007;23:40–5.

    Article  PubMed  Google Scholar 

  90. Choi-Kwon S, Choi J, Kwon SU, Kang DW, Kim JS. Fluoxetine is not effective in the treatment of post-stroke fatigue: a doubleblind, placebo-controlled study. Cerebrovasc Dis. 2007;23:103–8.

    Article  PubMed  Google Scholar 

  91. Zorowitz RD, Smout RJ, Gassaway JA, Horn SD. Usage of pain medications during stroke rehabilitation: the Post-Stroke Rehabilitation Outcomes Project (PSROP). Top Stroke Rehabil. 2005;12:37–49.

    Article  PubMed  Google Scholar 

  92. Kong KH, Woon VC, Yang SY. Prevalence of chronic pain and its impact on health-related quality of life in stroke survivors. Arch Phys Med Rehabil. 2004;85:35–40.

    Article  PubMed  Google Scholar 

  93. Paolucci S. Epidemiology and treatment of post-stroke depression. Neuropsychiatr Dis Treat. 2008;4:145–54.

    Article  PubMed Central  PubMed  Google Scholar 

  94. Lee HC, Lin HC, Tsai SY. Severely depressed young patients have over five times increased risk for stroke: a 5-year follow- up study. Biol Psychiatry. 2008;15:912–5.

    Article  Google Scholar 

  95. Nuyen J, Spreeuwenberg P. Impact of preexisting depression on length of stay and discharge destination among patients hospitalized for acute stroke. Stroke. 2008;39:132–8.

    Article  PubMed  Google Scholar 

  96. Sokero T, Melartin T, Rytsala H, Leskela U, Lestela-Mielonen L, Isometsa E. Prospective study of risk factors for attempted suicide among patients with DSM-IV major depressive disorder. Br J Psychiatry. 2005;186:314–8.

    Article  PubMed  Google Scholar 

  97. Joiner T, Conwell Y, Fitzpatrick K, Witte T, Schmidt N, Berlim M, Fleck M, Rudd M. Four studies on how past and current suicidality relate even when “everything but the kitchen sink” is covaried. J Abnorm Psychol. 2005;114:291–303.

    Article  PubMed  Google Scholar 

  98. Fawcett J, Scheftner W, Fogg L, Clark D, Youn M, Hedeker D, Gibbons R. Time-related predictors of suicide in major affective disorder. Am J Psychiatry. 1990;147:1189–94.

    Article  CAS  PubMed  Google Scholar 

  99. Younes N, Melchior M, Turbelin C, Blanchon T, Hanslik T, ChanChee C. Attempted and completed suicide in primary care: not what we expected? J Affect Disord. 2015;170:150–4.

    Article  CAS  PubMed  Google Scholar 

  100. Barbui C, Patten SB. Antidepressant dose and the risk of deliberate self-harm. Epidemiol Psychiatr Sci. 2014;14:1–3.

    Article  Google Scholar 

  101. Pompili M, Tondo L, Baldessarini RJ. Suicidal risk emerging during antidepressant treatment: recognition and intervention. Clin Neuropsychiatry. 2005;2(1):66–72.

    Google Scholar 

  102. Möller HJ, Baldwin DS, Goodwin G, Kasper S, Okasha A, Stein DJ, Tandon R, Versiani M. Do SSRIs or antidepressants in general increase suicidality? WPA Section on Pharmacopsychiatry: consensus statement. Eur Arch Psychiatry Clin Neurosci. 2008;258(Suppl 3):3–23.

    Article  PubMed  Google Scholar 

  103. Baldessarini RJ, Pompili M, Tondo L, Tsapakis E, Soldani F, Faedda GL, Hennen J. Antidepressants and suicidal behavior: are we hurting or helping? Clin Neuropsychiatry. 2005;2(1):75.

    Google Scholar 

  104. Thome J, Foley P. Agomelatine: an agent against anhedonia and abulia? J Neural Transm. 2013. doi: 10.1007/s00702-013-1126-6.

  105. Niedermaier N, Bohrer E, Schulte K, Schlattmann P, Heuser I. Prevention and treatment of poststroke depression with mirtazapine in patients with acute stroke. J Clin Psychiatry. 2004;65(12):1619–23.

    Article  CAS  PubMed  Google Scholar 

  106. Rasmussen A, Lunde M, Poulsen DL, Sørensen K, Qvitzau S, Bech P. A double-blind, placebo-controlled study of sertraline in the prevention of depression in stroke patients. Psychosomatics. 2003;44(3):216–21.

    Article  CAS  PubMed  Google Scholar 

  107. Jorge RE, Robinson RG, Arndt S, Starkstein S. Mortality and poststroke depression: a placebo-controlled trial of antidepressants. Am J Psychiatry. 2003;160(10):1823–9.

    Article  PubMed  Google Scholar 

  108. Fregni F, Pascual-Leone A. Transcranial magnetic stimulation for the treatment of depression in neurologic disorders. Curr Psychiatry Rep. 2005;7(5):381–90.

    Article  PubMed  Google Scholar 

  109. Kim BR, Kim DY, Chun MH, Yi JH, Kwon JS. Effect of repetitive transcranial magnetic stimulation on cognition and mood in stroke patients: a double-blind, sham-controlled trial. Am J Phys Med Rehabil. 2010;89(5):362–8. doi:10.1097/PHM.0b013e3181d8a5b1.

    Article  PubMed  Google Scholar 

  110. Bates KA, Rodger J. Repetitive transcranial magnetic stimulation for stroke rehabilitation-potential therapy or misplaced hope? Restor Neurol Neurosci. 2014;. doi:10.3233/RNN-130359.

    PubMed  Google Scholar 

Download references

Conflict of Interest

Professor Pompili, Dr. Venturini, Dr. Lamis, Dr. Giordano, Dr. Belvederi Murri, Dr. Serafini, Professor Amore, and Professor Girardi have no conflicts of interest to declare.

Funding Statement

No sources of funding were used to assist with the preparation of our paper.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Maurizio Pompili.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Pompili, M., Venturini, P., Lamis, D.A. et al. Suicide in Stroke Survivors: Epidemiology and Prevention. Drugs Aging 32, 21–29 (2015). https://doi.org/10.1007/s40266-014-0233-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40266-014-0233-x

Keywords

Navigation